发明名称 |
Enhancing a population of insulin releasing cells using GFR α-1 agonists |
摘要 |
Provided herein are pharmaceutical and transplant compositions and methods related to the treatment and prevention of diabetes. More specifically, the compositions and methods are related to activation of glial derived neurotrophic factor (GDNF) receptors or overexpression of the GFR-α1/c-Ret receptor complex in insulin secreting cells so as to promote cell survival and proliferation. |
申请公布号 |
US9133441(B2) |
申请公布日期 |
2015.09.15 |
申请号 |
US201314108531 |
申请日期 |
2013.12.17 |
申请人 |
EMORY UNIVERSITY |
发明人 |
Srinivasan Shanthi |
分类号 |
A61K38/00;C12N5/071;A61K38/18;A61K35/12 |
主分类号 |
A61K38/00 |
代理机构 |
Emory Patent Group |
代理人 |
Emory Patent Group |
主权项 |
1. A method of enhancing a population of pancreatic islet cells for transplantation comprising culturing the population of pancreatic islet cells with an effective amount of a GDNF polypeptide having SEQ ID NO: 9 or variants with at least 80% sequence identity to SEQ ID NO: 9. |
地址 |
Atlanta GA US |